Immune checkpoint inhibitors (ICIs) are a type of cancer treatment that help the body’s immune system better recognize and attack cancer cells. While they can be very effective, they sometimes cause the immune system to mistakenly attack healthy organs—like the kidneys—leading to a condition called ICI-associated acute kidney injury (ICI-AKI). We are starting to understand some of the clinical factors that increase the risk, and do analysis which part of population are most affected by using Logistic Regression, Kaplan Meir Analysis and Causal Methods.
